Video

Walgreens Senior Clinical Director on the Future of ACOs

Ed Cohen, PharmD, FAPhA, senior clinical director at Walgreens, talks about the future of ACOs.

Ed Cohen, PharmD, FAPhA, senior clinical director at Walgreens, talks about the future of ACOs.

This video was filmed at APhA’s Annual Meeting and Exposition in March 2015.

Related Videos
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit: Peter Hansen | stock.adobe.com
Older patient with medical health checkup with cardiologist or geriatric doctor. Woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Related Content
Image credit: AminaDesign | stock.adobe.com
May 23rd 2025

Oral GLP-1 Agonist Orforglipron Shows Promise for Type 2 Diabetes and Weight Management

Kennedy Ferruggia, Assistant Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Red ribbon for HIV/AIDS awareness -- Image credit: fizkes | stock.adobe.com
May 23rd 2025

A Student Pharmacist’s Guide to HIV Medications

Zahara Anglin, PharmD Candidate
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Skincare foam -- Image credit: Pavel | stock.adobe.com
Published: May 22nd 2025 | Updated: May 22nd 2025

FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis in Adults and Children

Gillian McGovern, Associate Editor
Visualization of human body with COPD highlighted on lungs | Image Credit: © Lila Patel - stock.adobe.com
May 22nd 2025

FDA Approves Mepolizumab for Treatment of Patients With COPD and an Eosinophilic Phenotype

Alexandra Gerlach, Associate Editor